多次每日胰岛素治疗的持续血糖监测：结果研究。
Continuous Glucose Monitoring with Multiple Daily Insulin Treatment: Outcome Studies.
作者信息
McGill Janet B, Ahmann Andrew
机构信息
1 Washington University in St. Louis , St Louis, Missouri.
2 Oregon Health & Science University , Portland, Oregon.
出版信息
Diabetes Technol Ther. 2017 Jun;19(S3):S3-S12. doi: 10.1089/dia.2017.0090.
Abstract
Continuous glucose monitoring (CGM) is developing into an increasingly useful tool for glucose monitoring and therapeutic guidance in the treatment of diabetes. Multiple daily doses of insulin (MDI) is the most common method for intensive insulin treatment of type 1 diabetes and is also becoming more common in the treatment of type 2 diabetes as an increasing population with type 2 diabetes experiences progressive beta cell loss. The clinical evidence demonstrating the benefit of CGM in the outcomes of patients treated with MDI is becoming clearer, particularly with the recent completion of several randomized clinical trials addressing both type 1 and 2 diabetes. This evidence is reviewed.
摘要
连续血糖监测（CGM）正逐渐发展成为一种在糖尿病治疗中用于血糖监测和治疗指导的日益有用的工具。多次皮下注射胰岛素（MDI）是1型糖尿病强化胰岛素治疗最常用的方法，随着2型糖尿病患者群体中β细胞渐进性丧失的情况日益增多，这种方法在2型糖尿病治疗中也越来越普遍。证明CGM对接受MDI治疗患者的预后有益的临床证据正变得越来越清晰，尤其是随着最近几项针对1型和2型糖尿病的随机临床试验的完成。本文对这一证据进行综述。
相似文献
1
Continuous Glucose Monitoring with Multiple Daily Insulin Treatment: Outcome Studies.
Diabetes Technol Ther. 2017 Jun;19(S3):S3-S12. doi: 10.1089/dia.2017.0090.
2
Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.
Diabetes Technol Ther. 2017 Jun;19(S3):S25-S37. doi: 10.1089/dia.2017.0035.
3
HypoDE: Research Design and Methods of a Randomized Controlled Study Evaluating the Impact of Real-Time CGM Usage on the Frequency of CGM Glucose Values <55 mg/dl in Patients With Type 1 Diabetes and Problematic Hypoglycemia Treated With Multiple Daily Injections.
J Diabetes Sci Technol. 2015 May;9(3):651-62. doi: 10.1177/1932296815575999. Epub 2015 Mar 9.
4
Differences in Use of Glucose Rate of Change (ROC) Arrows to Adjust Insulin Therapy Among Individuals With Type 1 and Type 2 Diabetes Who Use Continuous Glucose Monitoring (CGM).
J Diabetes Sci Technol. 2016 Aug 22;10(5):1087-93. doi: 10.1177/1932296816639069. Print 2016 Sep.
5
Continuous glucose monitoring for patients with type 1 diabetes on multiple daily injections of insulin: pros and cons.
Endocrine. 2018 Jan;59(1):62-65. doi: 10.1007/s12020-017-1328-z. Epub 2017 May 27.
6
Use of Glucose Rate of Change Arrows to Adjust Insulin Therapy Among Individuals with Type 1 Diabetes Who Use Continuous Glucose Monitoring.
Diabetes Technol Ther. 2016 Feb;18 Suppl 2(Suppl 2):S234-42. doi: 10.1089/dia.2015.0369.
7
Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
Diabetes Technol Ther. 2017 Jun;19(6):349-354. doi: 10.1089/dia.2016.0418. Epub 2017 Mar 15.
8
The use of continuous glucose monitoring in patients with type 2 diabetes.
Diabetes Technol Ther. 2012 Feb;14(2):190-5. doi: 10.1089/dia.2011.0086. Epub 2011 Sep 20.
9
Prolonged use of continuous glucose monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion or intensive multiple-daily injection therapy.
Pediatr Diabetes. 2009 Apr;10(2):91-6. doi: 10.1111/j.1399-5448.2008.00476.x. Epub 2008 Oct 20.
10
Multicentre randomized controlled trial with sensor-augmented pump vs multiple daily injections in hospitalized patients with type 2 diabetes in China: Time to reach target glucose.
Diabetes Metab. 2017 Sep;43(4):359-363. doi: 10.1016/j.diabet.2016.12.009. Epub 2017 Feb 21.
引用本文的文献
1
Combining uncertainty-aware predictive modeling and a bedtime Smart Snack intervention to prevent nocturnal hypoglycemia in people with type 1 diabetes on multiple daily injections.
J Am Med Inform Assoc. 2023 Dec 22;31(1):109-118. doi: 10.1093/jamia/ocad196.
2
Changes in glycaemic control of oral anti-diabetic medications assessed by continuous glucose monitors among patients with type 2 diabetes: a protocol of network meta-analysis.
Syst Rev. 2022 Jun 2;11(1):110. doi: 10.1186/s13643-022-01986-5.
3
Hybrid Closed-Loop Systems for the Treatment of Type 1 Diabetes: A Collaborative, Expert Group Position Statement for Clinical Use in Central and Eastern Europe.
Diabetes Ther. 2021 Dec;12(12):3107-3135. doi: 10.1007/s13300-021-01160-5. Epub 2021 Oct 25.
4
The Cost-Effectiveness of an Advanced Hybrid Closed-Loop System in People with Type 1 Diabetes: a Health Economic Analysis in Sweden.
Diabetes Ther. 2021 Nov;12(11):2977-2991. doi: 10.1007/s13300-021-01157-0. Epub 2021 Oct 1.
5
Flash glucose monitoring system: impact on glycemic control and body mass index in type 1 diabetes mellitus.
Arch Endocrinol Metab. 2021 Oct 29;65(5):640-647. doi: 10.20945/2359-3997000000405. Epub 2021 Sep 29.
6
Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls.
Diabetologia. 2021 Jul;64(7):1595-1603. doi: 10.1007/s00125-021-05437-z. Epub 2021 Mar 27.
7
Hypoglycemia in patient with type 2 diabetes treated with insulin: it can happen.
BMJ Open Diabetes Res Care. 2020 Jun;8(1). doi: 10.1136/bmjdrc-2020-001194.
8
Comparing effects of continuous glucose monitoring systems (CGMs) and self-monitoring of blood glucose (SMBG) amongst adults with type 2 diabetes mellitus: a systematic review protocol.
Syst Rev. 2020 May 31;9(1):120. doi: 10.1186/s13643-020-01386-7.
9
Hypoglycemia unawareness and autonomic dysfunction in diabetes: Lessons learned and roles of diabetes technologies.
J Diabetes Investig. 2020 Nov;11(6):1388-1402. doi: 10.1111/jdi.13290. Epub 2020 Jul 7.
10
Predicting and Preventing Nocturnal Hypoglycemia in Type 1 Diabetes Using Big Data Analytics and Decision Theoretic Analysis.
Diabetes Technol Ther. 2020 Nov;22(11):801-811. doi: 10.1089/dia.2019.0458. Epub 2020 May 14.
本文引用的文献
1
Diurnal Differences in Risk of Cardiac Arrhythmias During Spontaneous Hypoglycemia in Young People With Type 1 Diabetes.
Diabetes Care. 2017 May;40(5):655-662. doi: 10.2337/dc16-2177. Epub 2017 Feb 17.
2
Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.
JAMA. 2017 Jan 24;317(4):379-387. doi: 10.1001/jama.2016.19976.
3
Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
JAMA. 2017 Jan 24;317(4):371-378. doi: 10.1001/jama.2016.19975.
4
Continuous Glucose Monitoring in Patients With Type 1 Diabetes Taking Insulin Injections.
JAMA. 2017 Jan 24;317(4):363-364. doi: 10.1001/jama.2016.20327.
5
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY.
Endocr Pract. 2017 Feb;23(2):207-238. doi: 10.4158/EP161682.CS. Epub 2017 Jan 17.
6
Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial.
Diabetes Ther. 2017 Feb;8(1):55-73. doi: 10.1007/s13300-016-0223-6. Epub 2016 Dec 20.
7
8. Pharmacologic Approaches to Glycemic Treatment.
Diabetes Care. 2017 Jan;40(Suppl 1):S64-S74. doi: 10.2337/dc17-S011.
8
6. Glycemic Targets.
Diabetes Care. 2017 Jan;40(Suppl 1):S48-S56. doi: 10.2337/dc17-S009.
9
Role of continuous glucose monitoring for type 2 in diabetes management and research.
J Diabetes Complications. 2017 Jan;31(1):280-287. doi: 10.1016/j.jdiacomp.2016.10.007. Epub 2016 Oct 14.
10
Long-term Mortality and End-Stage Renal Disease in a Type 1 Diabetes Population Diagnosed at Age 15-29 Years in Norway.
Diabetes Care. 2017 Jan;40(1):38-45. doi: 10.2337/dc16-1213. Epub 2016 Oct 21.
Zotero 插件